Monitoring of Endothelial Cell Activation in Experimental Sepsis with a Two-step Cell Culture Model
Overview
Microbiology
Affiliations
The aim of this work was to establish and characterize a cell culture model for lipopolysaccharide (LPS)-induced activation of human endothelial cells. Monocytic THP-1 cells were stimulated for 4 h with 10 ng/ml LPS from Pseudomonas aeruginosa in media containing 10% human plasma. Culture supernatants containing LPS and factors secreted by THP-1 in response to stimulation were applied to human umbilical vein endothelial cells (HUVECs). Nuclear factor-κB (NF-κB) activity, expression of adhesion molecules, and cytokine secretion were quantified. In addition, the effect of adsorptive removal of tumour necrosis factor-α (TNF-α) from the THP-1 culture supernatant on HUVEC activation was assessed. After 4 h of stimulation, THP-1 cells secreted various mediators including TNF-α (854 ± 472 pg/ml), interleukin (IL)-8 (2069 ± 710 pg/ml), IL-18 (305 ± 124 pg/ml), IL-10 (14 ± 5 pg/ml), and IL-1β (24 ± 11 pg/ml). Stimulated HUVECs showed significantly increased NF-κB activity and secreted high amounts of IL-6 and IL-8. Additionally, adhesion molecules ICAM-1 and E-selectin were increased both in the culture supernatant and at the cell surface. Removal of TNF-α from the THP-1 culture supernatant prior to HUVEC stimulation resulted in a decrease in NF-κB activity, expression of adhesion molecules, as well as IL-6 secretion. The cell culture model established in this study permits the monitoring of LPS-induced endothelial activation, which plays a central role in sepsis and may serve to assess the effect of mediator modulation by methods such as extracorporeal blood purification.
Beyond Pattern Recognition: TLR2 Promotes Chemotaxis, Cell Adhesion, and Migration in THP-1 Cells.
Colleselli K, Ebeyer-Masotta M, Neuditschko B, Stierschneider A, Pollhammer C, Potocnjak M Cells. 2023; 12(10).
PMID: 37408259 PMC: 10217463. DOI: 10.3390/cells12101425.
Eisele J, Schreiner S, Borho J, Fischer S, Heber S, Endres S Front Pharmacol. 2022; 13:810611.
PMID: 35222028 PMC: 8881014. DOI: 10.3389/fphar.2022.810611.
Yang D, Zheng X, Chen S, Wang Z, Xu W, Tan J Nat Commun. 2018; 9(1):3052.
PMID: 30076291 PMC: 6076302. DOI: 10.1038/s41467-018-04984-1.
Tripisciano C, Weiss R, Eichhorn T, Spittler A, Heuser T, Fischer M Sci Rep. 2017; 7(1):6522.
PMID: 28747771 PMC: 5529579. DOI: 10.1038/s41598-017-03262-2.
Pfeiffer D, Rossmanith E, Lang I, Falkenhagen D PLoS One. 2017; 12(6):e0179850.
PMID: 28662100 PMC: 5491059. DOI: 10.1371/journal.pone.0179850.